ASPERGILLOSIS ORAL

This adverse event was reported 20 times

ASPERGILLOSIS ORAL is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ANTI-THYMOCYTE GLOBULIN (RABBIT) 5 0.0006
1 MICAFUNGIN SODIUM 1 0.0002
2 HUMAN INSULIN 1 0.0001
3 VANCOMYCIN HYDROCHLORIDE 1 0.0001
4 ACETYLCYSTEINE 1 0.0001
5 PEGASPARGASE 1 0.0001
6 METHYLPREDNISOLONE 10 0.0001
7 AZATHIOPRINE 6 0.0001
8 VORICONAZOLE 2 0.0001
9 MYCOPHENOLATE MOFETIL 9 0.0001
See all drugs enriched for association with ASPERGILLOSIS ORAL

ASPERGILLOSIS ORAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Echinocandin Antifungal [EPC] 1 0.0001
1 Asparagine-specific Enzyme [EPC] 1 0.0001
2 Purine Antimetabolite [EPC] 6 0.0001
3 Penem Antibacterial [EPC] 1 0.0000
4 Azole Antifungal [EPC] 4 0.0000
5 Insulin [EPC] 1 0.0000
6 CD20-directed Cytolytic Antibody [EPC] 6 0.0000
7 Antidote [EPC] 1 0.0000
8 Glycopeptide Antibacterial [EPC] 1 0.0000
9 HER2/neu Receptor Antagonist [EPC] 1 0.0000
See all drug classes enriched for association with ASPERGILLOSIS ORAL